Of note, this study considers only new patients calling in-network offices. We cannot measure access for established patients nor can we control for the myriad health system changes that occurred during the same period. While the 10 states were selected for diversity along a number of dimensions, our results may not be generalizable to other settings. Author Contributions: Drs Polsky and Candon had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis. 
HEALTH CARE REFORM

Health and Health Care Use Among Individuals at Risk to Lose Health Insurance With Repeal of the Affordable Care Act
Approximately 20 million individuals have gained health insurance under the Affordable Care Act (ACA), 1 including young adults covered under parental insurance, those purchasing private insurance on exchanges, and those covered through state Medicaid expansion.
As of mid-2016, 10.4 million individuals had private insurance policies through the exchanges, of whom 84% had incomes below 400% of the federal poverty level (FPL) and received premium tax credits. 2 Enrollment is projected at 13.8 million by the end of the open enrollment period in 2017. 3 State Medicaid expansion covered individuals with incomes below 138% FPL and included childless adults who were ineligible for Medicaid prior to the ACA. By 2016, over 14.6 million adults were enrolled in Medicaid under the "new adult" category, of which 11 million were newly eligible under the ACA. 4 Results of the 2016 US election suggest that the ACA may be repealed or modified.
Health and health care use by individuals at risk of losing health insurance should be better understood.
Methods | Using the Integrated Health Interview Series 5 of the 2015 National Health Interview Survey (NHIS), we identified 3 groups of adults younger than 65 years at risk to lose health insurance if premium tax credits are eliminated and Medicaid expansion is rolled back. The first group included adults with incomes below 400% FPL who purchased insurance through exchanges. If premium tax credits were to be removed, this group could experience substantial premium increases. The second group included childless adults with incomes below 138% FPL who are covered through Medicaid and who do not receive Social Security income due to disability. This group represents newly eligible Medicaid adults under the ACA. The third group included Medicaid-enrolled parents or adults in families with children who did not receive disability income and whose income was 50% to 138% FPL. Before the ACA, the median eligibility threshold across states was 61% FPL for parents or adult caretakers, 6 so a large portion of this group could lose coverage. We characterized sociodemographic characteristics, rates of chronic disease, and health care utilization, and compared the 3 groups with adults younger than 65 years with employer-sponsored insurance, a group unlikely to be affected by changes in subsidies on exchanges or to Medicaid. We used NHIS survey weights to produce nationally representative estimates. We used χ 2 tests for statistical comparisons between groups. Because we used publically available, previously collected, deidentified data, this study was exempt from institutional review board review.
Results | The NHIS was representative of 112 787 040 adults with employer-sponsored insurance, 6 799 679 adults in exchanges, 4 367 348 Medicaid childless adults, and 4 630 117 Medicaid parents or adult caretakers. Adults in the 3 groups at risk to lose insurance were significantly more likely to be
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Letters minorities, poor, and unemployed than adults in the employersponsored insurance group, and had significantly less educational attainment ( Table 1) . As compared with the employersponsored insurance group, adults in the 3 groups at risk to lose insurance had significantly higher rates of self-reported poor health and in many cases, but not all, were more likely to have certain chronic diseases, have visited the emergency department at least once, been hospitalized, and have 10 or more physician office visits in the past 12 months ( Table 2) .
Discussion | Our analysis highlights the socioeconomic vulnerability and rates of chronic diseases and health care utilization of individuals at risk to lose health insurance if the ACA is modified or repealed such that premium tax credits are eliminated and Medicaid expansion is rolled back. We did not include children who obtained coverage through exchanges, which accounts for approximately 16% of those with insurance through exchanges, nor considered the impacts of other possible ACA modifications, including changes to plan affordability, ; and quality of life in those with dementia is more tightly correlated with exposure to engaging activities than level of confusion or dementia. 4 With some variability, state statutes sharply restrict the circumstances in which clinicians may forgo life-sustaining treatment on the basis of a living will. In many states these directives to limit treatment are only effective if the patient is terminally ill, and in some states persistent vegetative state is also a qualifying condition. In a few states, advanced dementia is also qualifying. Living will laws tend to assume that preferences expressed in advance may be changed in the event of dementia and do not allow enforcement of an advance directive to withhold life-sustaining treatment for an incapacitated person in the event of, for example, incontinence.
Rubin and colleagues 1 In Reply Mansfield and Savaiano rightly point out that additional research is warranted to provide a more robust evidence base to inform policy decisions related to restricting the purchase of foods high in added sugars with Supplemental future research should examine effects among all household members over a longer period of time and in more population groups. In our study, 1 we point out 2 additional research needs.
First, future research should be carried out with SNAP participants or those eligible for SNAP. The population in our study 1 included those who were not eligible for SNAP but close to being eligible (near-eligible) or were eligible but not participating. Consequently, the external validity of the results may be limited. Many in the sample had a history of participating in SNAP. But, the most common reason cited for not currently participating was ineligibility (applied and not eligible or do not believe they are eligible). Restrictions may have a greater effect on diet in SNAP participants than our study participants because those in SNAP likely have lower incomes than the study sample. Those with lower incomes may be less apt to purchase restricted foods using personal funds (higher marginal propensity to spend food stamps). A second issue is that our study 1 relied on a self-report measure of diet. Self-report measures of diet are prone to measurement error including social desirability bias in reporting. Consequently, future studies should include nutritional biomarkers as an adjunct to self-report diet. 
Lisa Harnack, DrPH
Body Iron Stores and the Gender Gap in Risk of Incident Myocardial Infarction
To the Editor In a recent issue of JAMA Internal Medicine, Albrektsen and colleagues 1 in a large population-based prospective study found that the risk of myocardial infarction (MI) increased with age in both sexes, with lowest risk for women. This gender gap persisted throughout life, with a diminution of relative risk with age. Furthermore, the female advantage could not be explained by difference in the levels of traditional risk factors for coronary heart disease. However, the role of different body iron stores between sexes was not considered. The difference in incidence rate of MI between sexes parallels the difference in serum ferritin levels, a reliable indicator of body iron stores. In late adolescence, men begin a steady accumulation of storage iron with age, but women fail to acquire significant iron stores because of their continual losses of iron in menstrual blood, pregnancies, and deliveries. In particular, in a Danish population it has been shown that the rise of serum ferritin concentration in men reaches a plateau at 30 to 35 years of age. 2 Although the serum ferritin concentration is not significantly different in 30-, 40-, 50-, and 60-year-old men, the percentage of ample body iron stores (serum ferritin levels >300 μg/L) increases gradually from 5.9% at 30 years of age to 15.6% at 60 years of age. On the other hand, after cessation of menses due to natural menopause or to surgical removal of the uterus and/or the ovaries, there is a gradual increase in serum ferritin concentration, that reaches a plateau approximately 10 years after menopause, at a level which is slightly lower than in men. These changes in body iron stores resemble the incidence of MI in Denmark. 3 The biological plausibility of this association relies on the protective effect of iron depletion that may have multiple beneficial consequences through decreased availability of redox-active iron. The amount of free iron available at sites of oxidative or inflammatory injury appears to be a function of the stored iron level. Indeed, in a population of middle-aged and elderly men with peripheral arterial disease, phlebotomy of 1 unit of whole blood twice a year led to a significant decrease in overall mortality, myocardial infarction, and stroke over a several-year period, compared with the control group who did not receive phlebotomy. 4 Finally, the study by Albrektsen and colleagues 1 found only minor changes in the incidence rate of MI when moving from menopausal to postmenopausal women. This finding is consistent with epidemiological findings that premenopausal hysterectomy essentially cancels the protection even in cases with preservation of functioning ovaries. 5 On the contrary, these data 5 suggest that an intact uterus has an important role in the protection of premenopausal women, and likely this is related to the beneficial effect of iron depletion in menstruating women.
Luca Mascitelli, MD Mark R. Goldstein, MD
Author Affiliations: Comando Brigata Alpina "Julia"/Multinational Land Force, Medical Service, Udine, Italy (Mascitelli); NCH Physician Group, Naples, Florida (Goldstein).
ritin level as a potential confounder. An important interpretation of our results is that the risk in women seems to be unrelated to menopausal status or to any factors related to menopausal status. There appears to be no protection of being premenopausal vs postmenopausal above what can be explained by a difference in age. The declining relative risk for sex with increasing age seems to be a consequence of a more pronounced flattening of risk level changes in middle-aged men, approaching the risk level for women. This is in contrast to previous beliefs that the risk in women approximate the risk level for men at a certain age. As Mascitelli and Goldstein point out, the absolute risk of MI in women increases about a decade after normal menopausal age. However, an even steeper increase in risk is seen in men, leading to increasing sex differences in absolute risk with increasing age. It is thus difficult to explain the age incidence patterns in view of sex differences in ferritin levels. In a Danish population study 5 with follow-up through 1991, standardized age incidence curves were rather parallel for men and women (log-linear scale), in apparent contrast to the age-and sexrelated changes in body iron stores. In addition to increasing oxidative stress, increased iron stores have been suggested to promote CHD by alteration of endothelial function, decreased vascular reactivity, and reperfusion injury by iron-induced free radicals. 6 Different markers of body iron status have been used for testing the ironheart hypothesis in humans. Despite initial positive findings from experimental and preclinical research, conflicting results have emerged from epidemiological studies. 3, 6 The only large randomized clinical trial that assessed the effect of ironstore reduction by phlebotomy in patients with peripheral arterial disease found no significant association with allcause mortality or MI. 7 Mascitelli and Goldstein refer to results from age-specific analyses of data from this study. A positive effect of reduction in body iron stores were found only among persons in the lowest age quartile. Although the ferritin hypothesis is fascinating and has generated much research, there is no strong evidence for an association between body iron stores and risk of CHD. It is therefore less likely that body iron can explain the contrast in risk between sexes. However, body iron has been suggested to act synergistically with hypercholesterolemia. 3, 6 Thus, it is possible that ferritin levels act as effect modifier on the association with established CHD risk factors, and that sex differences in ferritin levels lead to sex heterogeneity in the association with these factors unless adjusted for in the analysis. Interaction effects involving body iron are not yet fully explored. Schofield and Henderson raised a question about the age-adjusted association between saturated fatty acid (SFA) intake and mortality in the Nurses' Health Study. Notably, the 2.3-year difference in age across quintiles of SFA intake in Table 1 was for baseline only. 1 All the variables (except those indicated as baseline variables), including diet and age, were updated every 2 to 4 years. During the follow-up, older participants reduced more SFA intake than their younger counterparts. Consequently, participants in the lowest quintile of SFA intake were much older than those in the highest quintile (mean difference, approximately 15 years), resulting in a strong confounding by age. Contrary to the assertion by Schofield and Henderson, our previous studies have demonstrated that self-reported smoking is highly reliable, 3 and self-reported smoking strongly predicted lung cancer incidence. 4 Furthermore, our analysis adjusted for both baseline and updated smoking status in very fine categories. We also found a significant positive association between SFA intake and respiratory disease mortality among never-smokers (hazard ratio for substituting 5% of energy from carbohydrates by the same energy from SFA, 1.36; 95% CI, 1.00-1.85) despite the small number of respiratory disease deaths in this subgroup. Thus, the hypothesized residual confounding due to underreport of smoking is unlikely to explain our findings. Plant oils have much higher amounts of polyunsaturated fatty acids (PUFA) than animal foods. For example, 100 g of cooked beef contains 0.43 g PUFA, whereas 100 g of soybean oil contains 57.7 g PUFA in the US Food Composition Databases. Given the benefits of replacing SFA by PUFA, recommending the replacement of high-SFA foods by high-PUFA foods is a sound population-wide approach to improving diet quality. Although α-linolenic acid intake was associated with slightly higher cancer mortality, we did not consider this association robust because it became nonsignificant in the sensitivity analysis that examined recent intake.
Lingering Questions Concerning Specific Dietary Fats and Mortality
In contrast to the claim by Schofield and Henderson, our study 1 provided strong evidence because of many repeated measurements of diet, validated measurement methods, and high follow-up rates over decades. More important, our analysis was able to directly compare SFA with other macronutrients in an isocaloric manner. Our findings are consistent with other highquality evidence, such as a pooled analysis of cohort studies that explicitly specified the comparison nutrients 5 and metaanalyses summarizing effects of replacing SFA by PUFA on both blood lipids 6 and cardiovascular disease 7 in randomized trials.
Overall, current evidence meets key Bradford-Hill criteria with regard to the strength and consistency of the evidence, biological plausibility, temporal relationships, and experimental evidence on intermediate biomarkers.
Incorrect Conclusions Concerning Antibiotics and Asthma Exacerbation
To the Editor We strongly support antibiotic stewardship, but we disagree with the statement, " also underpowered, as 199 of a planned 380 patients were randomized, and a significant treatment effect in favor of azithromycin could not be confidently excluded. Finally, the major reason for nonrecruitment was antibiotic receipt before screening (2044 screened patients were excluded for this reason), thus for each patient randomized, more than 10 patients failed screening because they had already received antibiotics. Such unexpectedly high antibiotic usage likely influenced study outcomes because patients who might have benefitted from antibiotic therapy for their asthma exacerbation were likely excluded from the study through already having received antibiotics. Patients being screened had often been seen by 3 independent physicians and/or teams (primary care, emergency department, and on-call respiratory and/or medical care physicians) who had assessed them for suitability for antibiotics prior to screening. As a result, those not prescribed antibiotics and therefore eligible for randomization were likely negatively selected against for suitability for antibiotics.
Thus, we do not agree with the statement in question. 2 Other studies that have reported benefit with antibiotics can be observed, 3 Current guidelines note that the role of bacterial infection in asthma exacerbation has been exaggerated and discourage use of antibiotics. 4 Of course there is a possibility that in the future we might identify a subgroup of patients with an asthma exacerbation who might benefit from antibiotics. But for now the answer is clear in terms of clinical practice: antibiotics should not be a standard component of asthma exacerbation treatment.
As the AZALEA trial 2 unfortunately demonstrated, there is gross overuse of antibiotics for asthma exacerbations. Such antibiotic use exposes patients to the harms of antibioticsincluding minor reactions like rashes and yeast infections, more severe allergic reactions, and Clostridium difficile infectionwith no apparent clinical benefit. As we discussed in our
